Site map

• About us
  • Environmental, social & governance
  • Global locations
  • Health regulations and standards
  • Our approach
  • Partnerships
    • Working with healthcare professionals
    • Working with insurers
    • Working with pharmaceutical and biotech companies
    • Working with the NHS
  • Patient care and safety
• Cancer
• Careers
• Christmas and New Year opening hours and delivery arrangements.  
• Contact us
• Cookie notice
• Digital solutions
  • Online communities
  • Sciensus NHS portal
• Gender pay gap report
• Google analytics notice
• Investors
• Knowledge hub
• Long-term conditions
• Low stock
• Meet us at the UK Oncology Forum 2024
• Meet us at the World Orphan Drug Congress 2024
• Modern slavery statement
• NHS cancer services
• Our markets
  • Intelligent Insights
• Partnership (Form)
• Patient consultation room
• Patient enquiry
• Patient hub
  • For cancer patients
  • New patients: where to start and what to expect
  • NHS patients
  • Private patients
  • Sciensus Intouch app
• Patient referral (form)
• Patient Resources
• Privacy notices
• Privacy notices
• Rare Diseases and Orphan Drugs
  • Early access program (EAP) 
    • Our expanded access programs solution
  • European drug approval pathway
  • Healthcare products (via Sciensus Axcess)
  • Orphan drugs supply chain management
  • Patient support programs for rare disease patients
  • Real world data for rare diseases
  • Regulatory approval consulting
• Sciensus analytics notice
• Sciensus Intouch terms of use
• Sciensus patient and carer representative
• Sciensus set to address patient support challenges in Europe at World Orphan Drug Congress 2024
• Services
  • Clinical trials
  • Virtual Wards
• Tax strategy
• Terms and conditions
  • Accessibility statement
• Terms and conditions for patient consultation room
• Treatments and eligibility